Jeanne Thoma insider trades: Ani Pharmaceuticals (ANIP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeanne reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | ANIP | ↓ Sell | 1,000 | $71.53 | $72K | Direct | Sep 14, 2026 (3d) |
| Aug 18, 2025 | ANIP | ↓ Sell | 21,540 | $89.15 | $1.9M | Direct | Aug 20, 2025 (2d) |
| Dec 20, 2021 | ANIP | ↑ Buy | 1,072 | $46.47 | $50K | Direct | Dec 22, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANIP insiders
Open-market trades in the last 12 months
About Jeanne Thoma's insider trades
Jeanne Thoma is a director at Ani Pharmaceuticals (ANIP). Since Dec 20, 2021, Jeanne has reported 1 open-market purchase worth $50K and 2 sales worth $2.0M on SEC Form 4. In the last 12 months: 1 sale ($72K).
Their filings also include grants and awards (13 filings), option exercises (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.